Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 19, 2000

View Archived Issues

Xechem awarded SBIR grant for marine extremophile research

Phase I trial shows excellent safety profile for NeoRx's STR agent

Avant Immunotherapeutics reports on TP-10 progress

Tripos and Parke-Davis to jointly develop high-throughput screening methods

Inflazyme selects nonemetic PDE4 inhibitor, updates status of other products

Enzo Biochem receives grant for HBV therapy

Provigil under study for several indications

TXU (anti-CD7)-PAP possesses good pharmacokinetics, low toxicity

AxyS announces combinatorial chemistry agreement with Searle

Hollis-Eden product shows efficacy in chloroquine-resistant malaria

IL-5 receptor antagonists discovered at Structural Bioinformatics

Therapeutically useful substituted oxazolidinones emerge from R&D at AstraZeneca

New beta-carbolines are somatostatin receptor ligands and sodium channel blockers

SB discloses newest selective dopamine D3 receptor ligands

Distamycin derivatives in development at Pharmacia & Upjohn

Glycine-antagonist tetrahydroquinoline derivatives designed at Glaxo Wellcome

Byk Gulden patents new PDE4 inhibitors

Merck KGaA designs nontoxic hypoglycemic agents particularly useful for NIDDM

Efforts at DuPont to design potent and selective alphavbeta3 antagonists successful

CKD-731: new fumagillin analogue shows potential as antiangiogenic agent

Antiplatelet agent OPC-29030 appears to act by inhibiting 12-lipoxygenase translocation

FemSoft Insert now commercially available in U.S. for treatment of incontinence

Avax Technologies' O-Vax IND accepted

First clinical results with 90Y-DOTATOC indicate antitumor efficacy, some safety problems

KeraVision commences clinical trials for use of Intacs as treatment of keratoconus

Avant's cholera vaccine to enter phase IIb trial

HIV gene medicine from Enzo progresses favorably in phase I trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...